People who take Pfizer's Covid antiviral treatment Paxlovid shortly after infection may reduce their risk of developing long Covid, regardless of their age, vaccination status or infection history, ...

COVID-19 is rising in prevalence in many states nationally following the July 4 holiday week, but the role of the main therapy to treat it—the antiviral drug Paxlovid—is less clear. Research studies ...

A summer COVID-19 surge has killed thousands of Americans and sent many more to hospitals, yet experts say some of those people would still be alive if they had taken a medication that studies show ...

NEW YORK -- When Laura Martin tested positive for COVID-19 last month during an extended stay in California, she was prescribed Paxlovid, the highly touted antiviral drug created by Pfizer. Just one ...

GoodRx, a platform for medication savings, is tracking prescription fills for medications that treat seasonal viral respiratory infections. The tracker includes fills for: These tools can be used ...

Traws Pharma Inc. (NASDAQ: TRAW) on Wednesday shared interim data from an ongoing randomized, open-label Phase 2 with ratutrelvir, an investigational oral, ritonavir-free Mpro/3CL protease inhibitor.

In recent days, analysts have repeatedly flagged ongoing competitive and pricing pressures on Pfizer’s key products, ...

Pfizer’s flagship Covid drug can have dangerous interactions with common medications, a review has found. Paxlovid gained emergency use authorization in the US in December last year as an antiviral ...

A company spokesperson on Wednesday confirmed the price, which was first reported by The Wall Street Journal. That list price, which is before rebates and other discounts to insurers and pharmacy ...